Literature DB >> 6283233

Distal nephron function in patients receiving chronic lithium therapy.

D Batlle, M Gaviria, M Grupp, J A Arruda, J Wynn, N A Kurtzman.   

Abstract

Renal tubular function was studied in 14 patients chronically treated with lithium for affective disorders. Patients were separated into two groups according to the duration of lithium therapy: long-term (35 +/- 7.0 months) and short-term (4.8 +/- 0.8 months). At comparable urine lithium concentrations, patients on long-term therapy had a lower maximal urine osmolality (Umax) and free water reabsorption (TcH2O) than did patients on short-term therapy. The latter group achieved a Umax above 800 mOsm kg H2O. In contrast, both groups of patients failed to increase the urine-blood (U-B) Pco2 gradient normally during acute sodium bicarbonate loading. This low U-B Pco2 was observed at comparable urine bicarbonate concentrations between both groups of patients and controls, and thus was associated with a higher urine pH in patients. These findings indicate that the inability of these patients to achieve a normal U-B Pco2 in a maximally alkaline urine was the result of decreased distal hydrogen ion secretion rather than inability to raise urine bicarbonate concentrations as a result of a concentrating defect. Bicarbonate reabsorptive capacity was normal in our lithium-treated subjects. Both groups of patients achieved a normal U-B Pco2 gradient in response to sodium phosphate loading. They also were able to achieve a minimal urine pH and a maximal acid excretion similar to those of controls in response to a 3-day ammonium chloride loading test. Our data demonstrate that chronic lithium therapy is associated with a mild distal acidification defect disclosed only by the finding of a low U-B Pco2 gradient during sodium bicarbonate loading. This peculiar defect can be found in short-term lithium-treated patients in whom the concentrating capacity is relatively well preserved.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283233     DOI: 10.1038/ki.1982.49

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Collecting duct intercalated cell function and regulation.

Authors:  Ankita Roy; Mohammad M Al-bataineh; Núria M Pastor-Soler
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-28       Impact factor: 8.237

2.  Lithium increases ammonium excretion leading to altered urinary acid-base buffer composition.

Authors:  Francesco Trepiccione; Claudia Altobelli; Giovambattista Capasso; Birgitte Mønster Christensen; Sebastian Frische
Journal:  J Nephrol       Date:  2017-11-24       Impact factor: 3.902

3.  Relationship of urinary and blood carbon dioxide tension during hypercapnia in the rat. Its significance in the evaluation of collecting duct hydrogen ion secretion.

Authors:  D C Batlle; M Downer; C Gutterman; N A Kurtzman
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

4.  Persistent nephrogenic diabetes insipidus, tubular proteinuria, aminoaciduria, and parathyroid hormone resistance following longterm lithium administration.

Authors:  W D Neithercut; R J Spooner; A Hendry; J H Dagg
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

Review 5.  Regulated acid-base transport in the collecting duct.

Authors:  Carsten A Wagner; Olivier Devuyst; Soline Bourgeois; Nilufar Mohebbi
Journal:  Pflugers Arch       Date:  2009-03-07       Impact factor: 3.657

6.  Characterization of acidification in the cortical and medullary collecting tubule of the rabbit.

Authors:  M E Laski; N A Kurtzman
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

7.  Oral acetazolamide in the assessment of (urine-blood) PCO2.

Authors:  U Alon; S Hellerstein; B A Warady
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

8.  Inhibition by lithium of the hydroosmotic action of vasopressin in the isolated perfused cortical collecting tubule of the rabbit.

Authors:  E Cogan; M Abramow
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.